Kinase backgrounder: Iressa discovery part of major kinase project at Dana-Farber
Many times in military history, a sudden attack by a small, fast-moving force has broken an impasse and helped turn the tide against an entrenched foe. In such situations, timing is everything....... Dana-Farber researchers, sensing an opening in the cancer battle, are mounting a quick thrust to flush out suspected molecular cancer triggers in tumor cells. Drug companies can then select specific...Dana-Farber launches Center for Applied Cancer Science
BOSTON--Dana-Farber Cancer Institute officials today announced the establishment of the Center for Applied Cancer Science, a far-reaching initiative designed to convert basic molecular discoveries into new therapies for cancer. The center is an integral part of Dana-Farber's strategic plan, which commits the Institute to making major advances in the development of cancer cures by accelerating the...Dana-Farber scientists discover natural blocker of HIV-1 virus
BOSTON--Researchers at Dana-Farber Cancer Institute have identified a protein in Old World monkeys that blocks infection by the human immunodeficiency virus (HIV-1). The finding could lead to improved animal models of AIDS for research and suggests that that a similar molecule known to exist in humans might be exploited for prevention and therapy. ...... Named TRIM5-alpha, the blocking molecule m...Dana-Farber researchers to lead collaborative smallpox studies
BOSTONThe National Institute of Allergy and Infectious Diseases (NIAID) announced today that it has selected Dana-Farber Cancer Institute to head one of five newly established Cooperative Centers for Translational Research on Human Immunology and Biodefense. ......Investigators at Dana-Farber and their colleagues from other Harvard Medical School-affiliated hospitals and the University of Massach...Dana-Farber launches NFCR Center for Therapeutic Antibody Research and Engineering
BOSTONThe Dana-Farber Cancer Institute and the National Foundation for Cancer Research (NFCR) announced today the establishment of the NFCR Center for Therapeutic Antibody Engineering at Dana-Farber to assist scientists in developing new antibodies for cancer research. The new center, directed by Wayne Marasco, MD, PhD, of Dana-Farber, brings some of the most advanced research on antibody enginee...